As of 30 Sep 2025, 54 institutional investors reported holding 19,704,437 shares of Silence Therapeutics plc - ADS (SLN).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 754,504 | $4,587,837 | -$853,923 | $6.08 | 17 |
| 2025 Q3 | 19,704,437 | $96,433,443 | -$511,345 | $5.19 | 54 |
| 2025 Q2 | 18,886,067 | $106,639,472 | -$14,651,800 | $5.80 | 54 |
| 2025 Q1 | 21,916,214 | $60,638,220 | -$13,764,100 | $2.82 | 58 |
| 2024 Q4 | 24,776,458 | $167,895,071 | -$84,830,810 | $6.88 | 63 |
| 2024 Q3 | 27,610,121 | $489,765,707 | -$39,910,866 | $18.18 | 68 |
| 2024 Q2 | 26,619,724 | $496,877,724 | -$26,602,120 | $19.00 | 69 |
| 2024 Q1 | 27,723,671 | $588,039,512 | +$163,408,487 | $21.60 | 64 |
| 2023 Q4 | 20,539,116 | $343,888,813 | +$16,651,031 | $17.37 | 33 |
| 2023 Q3 | 19,721,299 | $187,568,316 | +$5,649,220 | $9.82 | 28 |
| 2023 Q2 | 19,229,837 | $101,780,933 | +$4,398,936 | $5.50 | 29 |
| 2023 Q1 | 18,398,088 | $110,231,731 | -$8,695,582 | $6.20 | 29 |
| 2022 Q4 | 18,637,187 | $275,732,466 | +$658,683 | $15.25 | 27 |
| 2022 Q3 | 18,656,839 | $183,366,118 | +$89,229,344 | $10.03 | 29 |
| 2022 Q2 | 10,367,019 | $116,349,742 | -$33,812,492 | $11.85 | 24 |
| 2022 Q1 | 12,183,311 | $218,253,654 | +$34,480,267 | $19.00 | 25 |
| 2021 Q4 | 10,341,285 | $246,622,000 | +$171,435,592 | $23.89 | 21 |
| 2021 Q3 | 1,955,799 | $39,359,000 | -$5,425,411 | $20.61 | 7 |
| 2021 Q2 | 2,261,433 | $56,411,000 | -$6,759,844 | $25.78 | 6 |
| 2021 Q1 | 2,547,036 | $55,940,000 | +$44,883,578 | $23.01 | 6 |
| 2020 Q4 | 542,093 | $10,212,000 | +$2,000 | $21.51 | 3 |
| 2020 Q3 | 542,000 | $8,135,000 | +$8,135,024 | $15.50 | 2 |